Assessment of hepatic extraction fraction and input relative blood flow using dynamic hepatocyte‐specific contrast‐enhanced MRI

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Magnetic Resonance Imaging

• Publication date

  2009-06-01

• Fields of study

  Medicine, Chemistry, Engineering

• Identifiers
  DOI 10.1002/jmri.21801PMID 19472389
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Different Concentrations of I-123 MIBG and In-111 Pentetreotide in the Two Main Liver Lobes in Children: Persisting Regional Functional Differences After Birth?

  2007cited by this paper
• Model-Based Analysis of Gd-BOPTA-Induced MR Signal Intensity Changes in Cirrhotic Rat Livers

  2007cited by this paper
• MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA.

  2007cited by this paper
• Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy.

  2007cited by this paper
• Measurement of parenchymal function and bile duct flow in primary sclerosing cholangitis using dynamic 99mTc‐HIDA SPECT

  2006cited by this paper
• Comparison of Magnetic Properties of MRI Contrast Media Solutions at Different Magnetic Field Strengths

  2005cited by this paper
• Index terms:

  2005cited by this paper
• Perfusion imaging of the liver: current challenges and future goals.

  2005cited by this paper
• Principles of cerebral perfusion imaging by bolus tracking

  2005cited by this paper
• Different concentrations of various radiopharmaceuticals in the two main liver lobes: a preliminary study in clinical patients

  2005cited by this paper
• Quantification of Gd-BOPTA Uptake and Biliary Excretion From Dynamic Magnetic Resonance Imaging in Rat Livers: Model Validation With 153Gd-BOPTA

  2005cited by this paper
• Deconvolution analysis of dynamic contrast-enhanced data based on singular value decomposition optimized by generalized cross validation.

  2004cited by this paper
• Dynamic tests to study liver function.

  2004cited by this paper
• Gd-BOPTA Transport Into Rat Hepatocytes: Pharmacokinetic Analysis of Dynamic Magnetic Resonance Images Using a Hollow-Fiber Bioreactor

  2004cited by this paper
• Prognostic models including the Child-Pugh, MELD and Mayo risk scores--where are we and where should we go?

  2004cited by this paper
• Quantitative Evaluation of Liver Function with MRI Using Gd-EOB-DTPA

  2004cited by this paper
• Liver function: test selection and interpretation of results.

  2002cited by this paper
• Dynamic 99Tcm-HIDA SPET: non-invasive measuring of intrahepatic bile flow. Description of the method and a study in primary sclerosing cholangitis

  2001cited by this paper
• Optimal dose of Gd‐DTPA in dynamic MR studies

  2001influential reference
• Assessment of regional cerebral blood flow by dynamic susceptibility contrast MRI using different deconvolution techniques

  2000cited by this paper
• Evaluation of Regional Liver Function by Gadolinium-EOB-DTPA-Enhanced MR Imaging

  1999cited by this paper
• Validation of deconvolutional analysis for the measurement of hepatic function in dogs with toxic-induced liver disease.

  1998cited by this paper
• Experimental hepatic dysfunction: evaluation by MR imaging with Gd-EOB-DTPA.

  1998cited by this paper
• Experimental hepatic dysfunction: Evaluation by MRI with Gd‐EOB‐DTPA

  1997cited by this paper
• Terminology of liver anatomy and liver resections: coming to grips with hepatic Babel.

  1997cited by this paper
• Functional hepatobiliary imaging with gadolinium-EOB-DTPA. A comparison of magnetic resonance imaging and 153gadolinium-EOB-DTPA scintigraphy in rats.

  1996cited by this paper
• High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis

  1996cited by this paper
• Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging.

  1995cited by this paper
• Liver contrast media for magnetic resonance imaging. Interrelations between pharmacokinetics and imaging.

  1993cited by this paper
• Pharmacokinetics and clinical application of technetium 99m-labeled hepatobiliary agents.

  1990cited by this paper
• Measurement of hepatocellular function with deconvolutional analysis: application in the differential diagnosis of acute jaundice.

  1990cited by this paper
• Improved scintigraphic assessment of severe cholestasis with the hepatic extraction fraction

  1990cited by this paper
• Hepatocyte versus biliary disease: a distinction by deconvolutional analysis of technetium-99m IDA time-activity curves.

  1988cited by this paper
• The appended curve technique for deconvolutional analysis —method and validation

  1988cited by this paper
• Radionuclide evaluation of liver transplants.

  1988cited by this paper
• Quantitative scintigraphy with deconvolutional analysis for the dynamic measurement of hepatic function.

  1987cited by this paper
• Clinical Pharmacokinetics: Concepts and applications.

  1983cited by this paper
• The derivation of the gamma-variate relationship for tracer dilution curves.

  1983cited by this paper

• Role of Liver Function Assessment in Portal Venous Interventions and Locoregional Therapies for Liver Tumors.

  2025cites this paper
• Functional Dose-Volume Analysis Based on a Novel Image Biomarker Derived From Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Predicting Poststereotactic Body Radiation Therapy Liver Function Preservation in Patients With Hepatocellular Carcinoma

  2025cites this paper
• Continuing Professional Development – Medical Imaging

  2023cites this paper
• A gadoxetic-acid enhancement flux analysis of small liver nodules (≤2 cm) in patients at high risk of hepatocellular carcinoma.

  2023cites this paper
• Non‐contrast based approach for liver function quantification using Bayesian‐based intravoxel incoherent motion diffusion weighted imaging: A pilot study

  2023cites this paper
• Use of In Vivo Imaging and Physiologically-Based Kinetic Modelling to Predict Hepatic Transporter Mediated Drug–Drug Interactions in Rats

  2023cites this paper
• Determination of hepatic extraction fraction with gadoxetate low‐temporal resolution DCE‐MRI‐based deconvolution analysis: validation with ALBI score and Child‐Pugh class

  2022cites this paper
• Multiparametrische quantitative Magnetresonanztomografie bei Lebererkrankungen

  2021cites this paper
• A model selection framework to quantify microvascular liver function in gadoxetate‐enhanced MRI: Application to healthy liver, diseased tissue, and hepatocellular carcinoma

  2021cites this paper
• Concentrations and pharmacokinetic parameters of MRI and SPECT hepatobiliary agents in rat liver compartments

  2021cites this paper
• Validation study of perfusion parameter in hypervascular hepatocellular carcinoma and focal nodular hyperplasia using dynamic susceptibility magnetic resonance imaging with super-paramagnetic iron oxide: comparison with single level dynamic CT arteriography.

  2020cites this paper
• This is a repository copy of DCE-MRI for early prediction of response in hepatocellular carcinoma after TACE and sorafenib therapy: A pilot study . early prediction

  2020cites this paper
• Multiparametrische quantitative Magnetresonanztomografie bei Lebererkrankungen

  2020cites this paper
• Preoperative Remnant Liver Function Evaluation Using a Routine Clinical Dynamic Gd-EOB-DTPA-Enhanced MRI Protocol in Patients with Hepatocellular Carcinoma

  2020cites this paper
• Unusual Distribution Kinetics of Gadoxetate in Healthy Human Subjects Genotyped for OATP1B1: Application of Population Analysis and a Minimal Physiological-Based Pharmacokinetic Model.

  2020cites this paper
• Advances in Functional and Molecular MRI Technologies in Chronic Liver Diseases.

  2020cites this paper
• Image analysis methods for dynamic hepatocyte-specific contrast enhanced MRI

  2019influential citation
• A pharmacokinetic model including arrival time for two inputs and compensating for varying applied flip-angle in dynamic gadoxetic acid-enhanced MR imaging

  2019cites this paper
• Topics on quantitative liver magnetic resonance imaging.

  2019cites this paper
• Comparison between dynamic gadoxetate-enhanced MRI and 99mTc-mebrofenin hepatobiliary scintigraphy with SPECT for quantitative assessment of liver function

  2019cites this paper
• Child-Pugh Classification using Magnetic Resonance Imaging using Gadoxetic Acid-based Contrast Agent Compared with Indocyanine Green and 99mTc-galactosyl-human Serum Albumin Liver Scintigraphy

  2019cites this paper
• The role of imaging in prediction of post-hepatectomy liver failure.

  2018cites this paper
• Quantitative free-breathing dynamic contrast-enhanced MRI in hepatocellular carcinoma using gadoxetic acid: correlations with Ki67 proliferation status, histological grades, and microvascular density

  2018influential citation
• Quantification of hepatic perfusion and hepatocyte function with dynamic gadoxetic acid-enhanced MRI in patients with chronic liver disease.

  2018cites this paper
• Post-hepatectomy liver failure after major hepatic surgery: not only size matters

  2018cites this paper
• DCE-MRI for Early Prediction of Response in Hepatocellular Carcinoma after TACE and Sorafenib Therapy: A Pilot Study

  2018cites this paper
• Preoperative Evaluation of Liver Function

  2017cites this paper
• Current Modalities for the Assessment of Future Remnant Liver Function

  2017cites this paper
• Hepatic gadoxetic acid uptake as a measure of diffuse liver disease: Where are we?

  2017cites this paper
• Gadoxetate-enhanced MR imaging and compartmental modelling to assess hepatocyte bidirectional transport function in rats with advanced liver fibrosis

  2017cites this paper
• Recommendations on the use of magnetic resonance imaging in PSC‐A position statement from the International PSC Study Group

  2017cites this paper
• Vascular assessment of liver disease—towards a new frontier in MRI

  2016cites this paper
• Pre-treatment estimation of future remnant liver function using gadoxetic acid MRI in patients with HCC.

  2016cites this paper
• Quantitative Assessment of Liver Function Using Gadoxetate-Enhanced Magnetic Resonance Imaging

  2016cites this paper
• Molecular imaging and liver function assessment by hepatobiliary MRI.

  2016cites this paper
• BJRD15675 1..12

  2016cites this paper
• Imaging-based evaluation of liver function: comparison of 99mTc-mebrofenin hepatobiliary scintigraphy and Gd-EOB-DTPA-enhanced MRI

  2015cites this paper
• Imaging of HCC—Current State of the Art

  2015cites this paper
• Measurement of single-kidney glomerular filtration function from magnetic resonance perfusion renography.

  2015cites this paper
• Estimating Liver Perfusion From Free–Breathing Continuously Acquired Dynamic Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid–Enhanced Acquisition With Compressed Sensing Reconstruction

  2015cites this paper
• Advanced fibrosis: Correlation between pharmacokinetic parameters at dynamic gadoxetate-enhanced MR imaging and hepatocyte organic anion transporter expression in rat liver.

  2015cites this paper
• Prediction of liver cirrhosis, using diagnostic imaging tools.

  2015cites this paper
• Gadoxetic acid: pearls and pitfalls

  2015cites this paper
• Recent advances in estimating hepatic functional reserve in patients with chronic liver damage

  2015cites this paper
• New imaging techniques for liver diseases.

  2015cites this paper
• Bildgestützte Leberfunktionstests – Stand der Technik und zukünftige Entwicklungen Imaging-Based Liver Function Tests – Past , Present and Future

  2015cites this paper
• Imaging-Based Liver Function Tests – Past, Present and Future

  2015cites this paper
• The inhomogeneous distribution of liver function: possible impact on the prediction of post-operative remnant liver function.

  2015cites this paper
• Evaluation of Neuroendocrine Liver Metastases: A Comparison of Dynamic Contrast-Enhanced Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography

  2014cites this paper
• Optimized separation of left and right liver lobe in dynamic 99mTc-mebrofenin hepatobiliary scintigraphy using a hybrid SPECT-CT scanner

  2014cites this paper
• Evaluation of gadolinium-EOB-DTPA uptake after portal vein embolization: value of an increased flip angle

  2014cites this paper
• Relationship between severity of liver dysfunction and the relative ratio of liver to aortic enhancement (RE) on MRI using hepatocyte‐specific contrast

  2014cites this paper
• Comparison of CT and MRI artefacts from coils and vascular plugs used for portal vein embolization.

  2014cites this paper
• New Perspectives in the Assessment of Future Remnant Liver

  2014cites this paper
• Diagnostic accuracy of dynamic gadoxetic‐acid–enhanced MRI and PET/CT compared in patients with liver metastases from neuroendocrine neoplasms

  2014cites this paper
• Physiologically Realistic and Validated Mathematical Liver Model Revels Hepatobiliary Transfer Rates for Gd-EOB-DTPA Using Human DCE-MRI Data

  2014cites this paper
• DCE-MRI in hepatocellular carcinoma-clinical and therapeutic image biomarker.

  2014cites this paper
• Dynamic gadoxetate‐enhanced MRI for the assessment of total and segmental liver function and volume in primary sclerosing cholangitis

  2014cites this paper
• Consensus report from the 6th International forum for liver MRI using gadoxetic acid

  2014cites this paper
• Spatially resolved assessment of hepatic function using 99mTc-IDA SPECT.

  2013cites this paper
• Predictive Models for Regional Hepatic Function Based upon 99mTc-IDA SPECT and Local Radiation Dose for Physiological Adaptive RT

  2013cites this paper
• Gd-EOB-DTPA-enhanced MRI for the assessment of liver function and volume in liver cirrhosis.

  2013cites this paper
• Incidental focal hepatic mass.

  2013cites this paper
• Radiologic Assessment of Liver Fibrosis – Present and Future

  2013cites this paper
• Increase in left liver lobe function after preoperative right portal vein embolisation assessed with gadolinium-EOB-DTPA MRI

  2013cites this paper
• The Proper Scan Delay of the Hepatobiliary Phase of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging to Evaluate Small-Sized (≤ 3 cm) Hepatocellular Carcinoma in Cirrhotic Liver

  2013cites this paper
• Predictive models for regional hepatic function based on 99mTc-IDA SPECT and local radiation dose for physiologic adaptive radiation therapy.

  2013cites this paper
• Measuring hepatic functional reserve using low temporal resolution Gd-EOB-DTPA dynamic contrast-enhanced MRI: a preliminary study comparing galactosyl human serum albumin scintigraphy with indocyanine green retention

  2013cites this paper
• Assessing liver function using dynamic Gd‐EOB‐DTPA‐enhanced MRI with a standard 5‐phase imaging protocol

  2013cites this paper
• Feasibility study of in vivo MRI based dosimetric verification of proton end-of-range for liver cancer patients.

  2013cites this paper
• Contrast agents as a biological marker in magnetic resonance imaging of the liver: conventional and new approaches

  2012cites this paper
• Liver analysis using gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced magnetic resonance imaging: Correlation with histological grading and quantitative liver evaluation prior to hepatectomy

  2012cites this paper
• Liver MRI in the hepatocyte phase with gadolinium‐EOB‐DTPA: Does increasing the flip angle improve conspicuity and detection rate of hypointense lesions?

  2012cites this paper
• A Study of Correlation between Gd-EOB-DTPA-enhanced MRI Using the 3T MRI System and Tc-99m-GSA Hepatic Scintigraphy/Hepatic Function Tests in Prehepatectomy Cases

  2012cites this paper
• Combined quantification of liver perfusion and function with dynamic gadoxetic acid-enhanced MR imaging.

  2012cites this paper
• Primovist, Eovist: what to expect?

  2012cites this paper
• MRI of Focal Liver Lesions

  2012cites this paper
• CASE OF THE MONTH Incidental focal hepatic mass

  2012cites this paper
• Assessment of Hepatic Function with Gd-EOB-DTPA-Enhanced Hepatic MRI

  2012cites this paper
• Neuere Entwicklungen der Leber-MRT

  2011cites this paper
• [New developments in MRI of the liver].

  2011cites this paper
• Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging--preliminary observations.

  2011cites this paper
• Consensus Report of the 4th International Forum for Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid Magnetic Resonance Imaging

  2011cites this paper
• Chronological evaluation of liver enhancement in patients with chronic liver disease at Gd-EOB-DTPA-enhanced 3-T MR imaging: does liver function correlate with enhancement?

  2011cites this paper
• Human Whole Body Pharmacokinetic Minimal Model for the Liver Specific Contrast Agent Gd-EOB-DTPA

  2011cites this paper
• Gd-EOB-DTPA-enhanced liver MR imaging: correlation with liver function tests

  2011cites this paper
• Quantitative evaluation of liver function with use of gadoxetate disodium-enhanced MR imaging.

  2011cites this paper
• Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients

  2011cites this paper
• Quantitative Magnetic Resonance in Diffuse Neurological and Liver Disease

  2010cites this paper
• Consensus Report of the Third International Forum for Liver Magnetic Resonance Imaging

  2010cites this paper
• Quantitative Evaluation of Contrast Agent Dynamics in Liver MRI

  2010cites this paper
• Gadoxetate disodium-enhanced MRI of the liver: part 2, protocol optimization and lesion appearance in the cirrhotic liver.

  2010cites this paper
• Assessment of liver function in primary biliary cirrhosis using Gd-EOB-DTPA-enhanced liver MRI.

  2010cites this paper
• Technical aspects of MR perfusion.

  2010cites this paper
• Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging--correlation with expression of sinusoidal and canalicular transporters and bile accumulation.

  2010cites this paper
• Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver.

  2010cites this paper
• Liver parenchymal enhancement of hepatocyte‐phase images in Gd‐EOB‐DTPA‐enhanced MR imaging: Which biological markers of the liver function affect the enhancement?

  2009cites this paper
• Gadoxetic acid (Gd-EOB-DTPA) in contrast-enhanced MRI for the diagnosis of hepatocellular carcinoma

  2009cites this paper
• Hepatocellular Carcinoma Cirrhosis of Liver Magnetic Resonance Imaging Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid The Proper Scan Delay of the Hepatobiliary Phase of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging to Evaluate Small-Sized ( ≤ 3 cm ) Hepatocellular Carcinoma in Cir

  year unknowncites this paper